Clinical Trial Update: Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment

View source ↗

Summary

A discrete-choice experiment study to understand patient and physician treatment preferences for metastatic prostate cancer in Hong Kong, sponsored by the Chine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Prostate Cancer | Status: RECRUITING